Xeris Pharmaceuticals Inc reported $87.71M in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acelrx Pharmaceuticals ACRX:US $ 6.95M 2.42M
Acura Pharmaceuticals ACUR:US 404K 33K
Eli Lilly And LLY:US $ 15522.4M 785.8M
Endo International Ordinary Shares ENDP:US $ 8070.77M 3.67M
Horizon Pharma HZNP:US $ 2557.86M 2.58M
JAZZ PHA JAZZ:US $ 6253.65M 241.68M
Nektar Therapeutics NKTR:US $ 0M 0M
Pacira Pharmaceuticals PCRX:US $ 326.15M 4.44M
Perrigo Ordinary Shares PRGO:US $ 2920.9M 4.9M
Supernus Pharmaceuticals SUPN:US $ 374.79M 4.4M
Teva Pharmaceutical Industries TEVA:US $ 21037M 565M
Zogenix ZGNX:US $ 155.87M 2.24M